Potential role of chemo-radiation with oral capecitabine in a breast cancer patient with central nervous system relapse
- 28 February 2006
- journal article
- case report
- Published by Elsevier in The Breast
- Vol. 15 (1) , 97-99
- https://doi.org/10.1016/j.breast.2005.03.006
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Toxicity of treatment for neoplastic meningitis.Current Oncology Reports, 2003
- IntroductionThe Oncologist, 2002
- Capecitabine for 5-Fluorouracil-Resistant Brain Metastases From Breast CancerAmerican Journal of Clinical Oncology, 2001
- High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxelAnnals of Oncology, 2001
- Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast CancerJournal of Clinical Oncology, 1999
- Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissuePublished by Elsevier ,1998
- Leptomeningeal metastases from solid tumorsCancer, 1998
- Current diagnosis and treatment of leptomeningeal metastasisJournal of Neuro-Oncology, 1998
- Carcinomatous meningitis in patients with breast cancer. An aggressive disease variantCancer, 1994
- Passage of 5'-dFUrd and its metabolites 5-FU and 5-FUH2to CSF in a clinical Phase 1 studyActa Neurologica Scandinavica, 1986